Clinical features of Pompe disease

Acta Myologica

Volumn 32, Issue 2, 2013, Pages 82-84

  Manganelli, Fiore ^a   Ruggiero, Lucia ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

GAA activity; Glycogen storage disease type II; Pompe disease

Indexed keywords

GLUCAN 1,4 ALPHA GLUCOSIDASE; GLYCOGEN; ALPHA GLUCOSIDASE;

ARTICLE; CHROMOSOME 17Q; CLINICAL FEATURE; DISEASE SEVERITY; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; LYSOSOME; NEUROMUSCULAR DISEASE; PHENOTYPE; DIFFERENTIAL DIAGNOSIS; GAA ACTIVITY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUSCLE WEAKNESS; MUTATION; ONSET AGE; PATHOPHYSIOLOGY; PROGNOSIS;

GAA ACTIVITY; GLYCOGEN STORAGE DISEASE TYPE II; POMPE DISEASE;

AGE OF ONSET; ALPHA-GLUCOSIDASES; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; GLYCOGEN; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; LYSOSOMES; MUSCLE WEAKNESS; MUTATION; PROGNOSIS;

EID: 84894456805     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. van der Ploeg AT Reuser AJ. Pompe's disease. Lancet 2008;372:1342-53
2. Raben N Roberts A Plotz PH. Role of autophagy in the pathogenesis of Pompe disease. Acta Myol 2007;26:45-8
3. Hagemans ML Winkel LP Van Doorn PA et al. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain 2005;128:671-7
4. van der Beek NA de Vries JM Hagemans ML et al. Clinical features and predictors for disease natural progression in adults with Pompe disease: A nationwide prospective observational study. Orphanet J Rare Dis 2012;7:88
5. Müller-Felber W Horvath R Gempel K et al. Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease. Neuromuscul Disord 2009;19:113-17
6. Alejaldre A D́az-Manera J Ravaglia S et al. Trunk muscle involvement in late-onset Pompe disease: Study of thirty patients. Neuromuscul Disord 2012;22 Suppl 2:S148-54
7. Hobson-Webb LD Jones HN Kishnani PS. Oropharyngeal dysphagia may occur in late-onset Pompe disease implicating bulbar muscle involvement. Neuromuscul Disord 2013;23:319-23
8. Mellies U Lofaso F. Pompe disease: A neuromuscular disease with respiratory muscle involvement. Respir Med 2009;103:477-84
9. van der Beek NA van Capelle CI van der Velden-van Etten KI et al. Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease. Mol Genet Metab 2011;104:129-36
10. American Association of Neuromuscular & Electrodiagnostic Medicine. Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve 2009;40:149-60
11. Spada M Porta F Vercelli L et al. Screening for later-onset Pompe's disease in patients with paucisymptomatic hyperCKemia. Mol Genet Metab 2013;109:171-3
12. Schlotter-Weigel B Lochmüller H Schoser B. Late onset Pompe disease: Clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord 2007;17:698-706
13. Hobson-Webb LD Dearmey S Kishnani PS. The clinical and electrodiagnostic characteristics of Pompe disease with post-enzyme replacement therapy findings. Clin Neurophysiol 2011;122:2312-7
14. Carlier RY Laforet P Wary C et al. Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns. Neuromuscul Disord 2011;21:791-9
15. Goldstein JL Young SP Changela M et al. Screening for Pompe disease using a rapid dried blood spot method: Experience of a clinical diagnostic laboratory. Muscle Nerve 2009;40:32-6
16. Vissing J Lukacs Z Straub V. Diagnosis of Pompe Disease: Muscle biopsy vs blood-based assays. JAMA Neurol 2013;70:923-7
17. Chien YH Hwu WL Lee NC. Pompe disease: Early diagnosis and early treatment make a difference. Pediatr Neonatol 2013;54:219-27
18. Dubrovsky A Corderi J Karasarides T et al. Pompe disease the must-not-miss diagnosis: A report of 3 patients. Muscle Nerve 2013;47:594-600.